Stoke Therapeutics, Inc. STOK Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Stoke Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s common stock?
- Stoke Therapeutics, Inc. (STOK) reported common stock of $6K in Q1 2026.
- How has Stoke Therapeutics, Inc.'s common stock changed year-over-year?
- Stoke Therapeutics, Inc.'s common stock increased by 20.0% year-over-year, from $5K to $6K.
- What is the long-term trend for Stoke Therapeutics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s common stock has grown at a 4.6% compound annual growth rate (CAGR), from $4K to $5K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).